Evaluation of pain and quality of life using Uncaria Tomentosa (cat's claw) in patients with endometriosis

Evaluation of pain and quality of life using Uncaria Tomentosa (cat's claw) in patients with endometriosis. - there is not

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

REBEC

Registry ID

RBR-8mrhgcc

Enrollment

Unknown

Registered

2021-02-01

Start date

2021-03-01

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis, pelvic pain

Interventions

The study will be a randomized, double-blind clinical trial, whose sample will consist of 42 women diagnosed with endometriosis who maintain pain even when using treatment with hormonal contraceptives

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria are patients with a diagnosis of endometriosis, confirmed by image examination, who maintain pain (visual analogue scale> 5) even when using drug treatment with hormonal contraceptives for at least 3 months before inclusion in the study.

Exclusion criteria

Exclusion criteria: Exclusion criteria are patients without other types of clinical treatment, such as anastrozole, gestrionone, GnRH analogue; patients who are undergoing complementary treatment with physiotherapy, acupuncture, meditation; patients who are planning to become pregnant, pregnant and / or lactating, use opioid-based painkillers or who are diagnosed with another pelvic disease such as intestinal and urinary disorders.

Design outcomes

Primary

Measure	Time frame
It is expected to find a difference in the use of Uncaria tomentosa for pain control in patients with endometriosis.	—

Countries

Brazil

Contacts

Public ContactEduardo Schor

eduardo@clinicaschor.med.br+ 55 11 5576 4848 VoIP 2856

Outcome results

None listed

Source: REBEC (via WHO ICTRP)